ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
ResMed (RMD) Tops Q4 EPS by 1c, Revenues Beat
July 25, 2019 4:27 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.95, $0.01 better than the analyst estimate of $0.94. Revenue for the quarter came in at $705 million versus the consensus estimate of $702.28 million.
Fourth Quarter 2019 Highlights
Revenue increased 13% to $705.0 million; up 15% on a constant currency basisGross margin expanded 120 bps... More


